PRTA · Prothena Corp Public Ltd Co · Executive Compensation

$8.16 -0.07 (-0.85%) At close · Nov 13 Play latest call Q4 2025 earnings call transcript

Russell 2000 member Rebalance outlook locked

Market Cap

$419.01M

51.35M

Volume · Nov 13 340.75K Avg daily vol (3M) 464.03K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gene Kinney	President and Chief Executive Officer	$538,125	—	—	$2,338,354	$322,875	$14,000	$3,213,354
Michael J. Malecek	Chief Legal Officer and Company Secretary	$207,692	$125,000	—	$1,787,925	$160,000	$8,400	$2,289,017
Tran B. Nguyen	Chief Operating Officer and Chief Financial Officer	$430,500	—	—	$906,709	$215,250	$14,000	$1,566,459
Carol D. Karp	Chief Regulatory Officer	$423,120	—	—	$477,215	$169,248	$14,000	$1,083,583
Radhika Tripuraneni	M.D., M.P.H. Chief Development Officer	$403,199	—	—	$477,215	$161,280	$14,000	$1,055,694

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gene Kinney	President and Chief Executive Officer	$525,000	—	—	$10,575,894	$283,500	$12,375	$11,396,769
Tran B. Nguyen	Chief Operating Officer and Chief Financial Officer	$412,500	—	—	$4,359,215	$173,143	$12,375	$4,957,233
Carol D. Karp	Chief Regulatory Officer	$410,667	—	—	$2,862,855	$151,947	$12,375	$3,437,844

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gene Kinney	President and Chief Executive Officer	$520,833	—	—	$4,301,412	$312,500	$13,500	$5,148,245
Tran B. Nguyen	Chief Operating Officer and Chief Financial Officer	$399,167	—	—	$2,688,383	$159,667	$13,500	$3,260,717
Carol D. Karp	Chief Regulatory Officer	$400,000	—	—	—	$160,000	$13,500	$573,500

Executive changes

Person	Role	Change	Effective	Filed
Chad J. Swanson	Chief Development Officer	Resigned	2026-10-09	2026-10-02
Paula Cobb	Board of Directors	Resigned	2025-12-31	2025-12-12
David A. Ford	Chief People Officer	Terminated	2025-08-01	2025-06-18
Carol D. Karp	Chief Regulatory Officer	Terminated	2025-08-01	2025-06-18
Oleg Nodelman	Board of Directors	Resigned	2024-12-31	2024-12-30
Chad J. Swanson, Ph.D.	Chief Development Officer	Appointed	—	2024-09-27
Hideki Garren, M.D., Ph.D.	Chief Medical Officer	Resigned	2024-09-27	2024-09-27
Daniel G. Welch	director	Appointed	2024-02-21	2024-02-21
William H. Dunn, Jr., M.D.	director	Appointed	2023-05-16	2023-05-16
Dr. Sanjiv K. Patel	Director and member of the Compensation Committee of the Board	Resigned	2023-07-01	2023-04-28
Helen S. Kim	director	Appointed	2022-08-30	2022-09-01

Leadership

Gene Kinney CEO, Board Member
Lars G. Ekman Chairman, Board Member
Brandon S. Smith COO, Board Member
Brandon Smith Board Member
Carol D. Karp Board Member
Daniel G. Welch Board Member
Dennis J. Selkoe Board Member
Helen S. Kim Board Member
Richard T. Collier Board Member
Sanjiv K. Patel, Ph.D. Board Member
Shane M. Cooke Board Member
Tran B. Nguyen Board Member
Tran Nguyen Board Member
Wagner Zago Board Member
William H. Dunn Board Member
William H. Dunn, Jr., M.D. Board Member

Key facts CIK 1559053 CUSIP G72800108 13F (30d) 149 filings 122 filers Visit website Investor relations